IDH2 and CD28 mutations were seen in only AITL (25%, 4% respectively), and not in PTCL‐TFH, with mutation in the remaining genes being at low frequencies in both groups. Here, IDH2 is linked to angioimmunoblastic T-cell lymphoma.